INTERNATIONAL SOCIETY FOR INFECTIO… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1983

Legal Domicile

Principal Officer

LINDA MACKINNON

Phone

6179255272

Tax Period

2023-01-01 to 2023-12-31

INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES INC, founded in 1983, is a community nonprofit in the Diseases & Disorders sector that reported $3.3M in total revenue in fiscal year 2023. Revenue grew 17% year-over-year, indicating healthy expansion. Expenses of $2.9M left a modest 14% surplus.

Mission

THE MISSION OF INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES IS TO SUPPORT HEALTH PROFESSIONALS, NON-GOVERNMENT ORGANIZATIONS, AND GOVERNMENTS AROUND THE WORLD IN THEIR WORK TO PREVENT, INVESTIGATE AND MANAGE INFECTIOUS DISEASE OUTBREAKS WHEN THEY OCCUR, PARTICULARLY IN COUNTRIES THAT HAVE LIMITED RESOURCES AND WHICH DISPROPORTIONATELY BEAR THE BURDEN OF INFECTIOUS DISEASES.

Program Service Accomplishments

Program 1

Expenses: $2,209,574 Revenue: $947,547

ISID CONTINUES TO INCREASE THE KNOWLEDGE BASE OF INFECTIOUS DISEASE PRACTITIONERS WITHIN A ONE HEALTH CONTEXT THROUGHOUT THE WORLD AT LARGE. THROUGH RESEARCH, MENTORSHIP, AND CONTENT GENERATION, ISID ENHANCES PROFESSIONAL DEVELOPMENT OF INDIVIDUALS IN THIS DISCIPLINE. FROM SMALL GRANTS PROGRAMS TO LARGE SCALE CONGRESS PROGRAMMING, ISID IS A LEADER IN FOSTERING THE DEVELOPMENT OF EARLY CAREER INFECTIOUS DISEASE PROFESSIONALS WITHIN DEVELOPING ECONOMIES. ISID IS THE INNOVATOR IN EMERGING DISEASES OUTBREAK DETECTION AND SHARES MILLIONS OF REAL-TIME ALERTS TO SUBSCRIBER EMAILS EVERY MONTH. ISID PUBLISHES 3 PEER-REVIEWED OPEN-ACCESS SCIENTIFIC JOURNALS ONLINE WHICH ALLOWS SCIENTISTS FROM ALL COUNTRIES TO UPDATE THEIR KNOWLEDGE ON NEW CLINICAL SCIENCE AND SKILLS IN THE FIELD OF INFECTIOUS DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,060,988

Program Service Revenue $457,824

Investment Income $324,986

Other Revenue $489,723

TOTAL REVENUE $3,333,521

Expense Breakdown

Grants Paid $105,000

Salaries & Benefits $1,389,296

Fundraising Expenses $81,542

Program Expenses $2,209,574

Other Expenses $1,370,560

TOTAL EXPENSES $2,864,856

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,333,521	$2,861,337	+0.2%
Expenses	$2,864,856	$4,101,295	-0.3%
Net Income	$468,665	$-1,239,958	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$363,495

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAFFAR AL-TAWFIQ	BOARD MEMBER	1.00	Director	$0	$0	$0
GONZALO BEARMAN	BOARD MEMBER	1.00	Director	$0	$0	$0
HELENA MALTEZOU	BOARD MEMBER	1.00	Director	$0	$0	$0
CONNIE WALYARO	BOARD MEMBER	1.00	Director	$0	$0	$0
ROBERT HEYDERMAN	BOARD MEMBER	1.00	Director	$0	$0	$0
NEELIKA MALAVIGE	BOARD MEMBER	1.00	Director	$0	$0	$0
ALLISON HOLMES	PAST PRESIDENT	1.00	Director	$0	$0	$0
PAUL TAMBYAH	PRESIDENT	1.00	Officer Director	$0	$0	$0
SALLY ROBERTS	TREASURER & PRESIDENT ELECT	1.00	Officer Director	$0	$0	$0
LINDA MACKINNON	CEO	40.00	Officer	$239,684	$16,157	$255,841
CHRISTOPHER WIDMER	COO	40.00	Officer	$90,850	$16,804	$107,654
CATHERINE CROWLEY	DIRECTOR OF BUSINESS DEVELOPMENT	40.00	Highest	$122,174	$9,004	$131,178
JULIA MAXWELL	DIRECTOR OF DISEASE SURVEILLANCE	40.00	Highest	$119,871	$8,961	$128,832

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,333,521	$2,864,856	$2,986,201	$468,665
2022	$2,861,337	$4,101,295	$2,622,557	$-1,239,958
2021	$2,195,925	$3,277,028	$4,197,503	$-1,081,103
2020	$3,298,662	$2,931,939	$5,661,861	$366,723
2019	$3,054,906	$2,189,371	$4,762,008	$865,535
2018	$2,830,341	$3,620,485	$3,380,743	$-790,144

INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES INC